PIN9 CLINICAL PRACTICE EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF HEPATITIS B IN THE US

Authors :: L. Frazier
H.W. Hann
H. Bae
V. Ankoma-Sey
W.R. Kim
Douglas T. Dieterich
J. Radtchenko
Nezam H. Afdhal
M. Tong
Scott Milligan
C. Pan
R. Reddy
P. Kwo
Michael P. Curry
Source :: Value in Health. 22:S196
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Clinical Practice
Oncology
medicine.medical_specialty
business.industry
Health Policy
Internal medicine
Public Health, Environmental and Occupational Health
medicine
Hepatitis B
medicine.disease
business
Tenofovir alafenamide

Tools